Source: Affinity Life Sciences Blog

Affinity Life Sciences Blog Hytest Ltd. Signs Exclusive Development Agreement with Affinity Life Sciences

HyTest Ltd., a continually expanding Finnish biotechnology company known for high quality products for assay development and research applications, signed an exclusive agreement with Affinity Life Sciences to develop and manufacture research assays for their proprietary SES-BNP technology for detection of proBNP / BNP. Brain...The post Hytest Ltd. Signs Exclusive Development Agreement with Affinity Life Sciences appeared first on Affinity Life Sciences.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
CEO Avatar

President

Tod Gavron

CEO Approval Rating

85/100

Read more